Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib

被引：0
|
作者：
Weinblatt, Michael [1 ]
Thomson, Glen [2 ]
Chen, Kun [3 ]
Meerwein, Sebastian [4 ]
Schlacher, Casey [3 ]
Cush, John [5 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] CIADS Res, Winnipeg, MB, Canada
[3] AbbVie Inc, N Chicago, IL USA
[4] AbbVie GmbH Co KG, Ludwigshafen, Germany
[5] Baylor Univ, Med Ctr, Dallas, TX USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0515
引用
收藏
页数：3
相关论文
共 50 条
  • [41] DOSE ESCALATION OF UPADACITINIB IN CROHN'S DISEASE PATIENTS WITH INADEQUATE RESPONSE: DATA FROM THE RANDOMISED CELEST STUDY
    Sandborn, William J.
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Louis, Edouard
    Greenbloom, Susan
    Zhou, Wen
    Zhou, Qian
    Liu, Jianzhong
    Lacerda, Ana P.
    GASTROENTEROLOGY, 2020, 158 (06) : S1187 - S1187
  • [42] Dose escalation of upadacitinib in Crohn's disease patients with an inadequate response: Data from the randomised CELEST study
    Sandborn, W.
    Panes, J.
    Peyrin-Biroulet, L.
    Louis, E.
    Greenbloom, S.
    Zhou, W.
    Zhou, Q.
    Liu, J.
    Lacerda, A. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S117 - S118
  • [43] Are There Any Associations between ANA Development and Poor Treatment Response to Bdmards in RA Patients?
    Ishikawa, Yuki
    Hashimoto, Motomu
    Ito, Hiromu
    Tanaka, Masao
    Yukawa, Naoichiro
    Fujii, Takao
    Yamamoto, Wataru
    Mimori, Tsuneyo
    Terao, Chikashi
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND UP TO 6.9-YEARS OF TREATMENT
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    Pile, Kevin
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 35 - 35
  • [45] Impact of 12-Weeks of Upadacitinib Treatment on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic or Biologic DMARDs
    van Vollenhoven, Ronald
    Dore, Robin K.
    Chen, Kun
    Camp, Heidi S.
    Enejosa, Jose Jeffrey
    Shaw, Tim
    Suboticki, Jessica
    Hall, Stephen
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [46] Inadequate stress responses in clinical simulations
    Patrick, Kelly
    MEDICAL TEACHER, 2017, 39 (07) : 786 - 786
  • [47] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND UP TO 6.9-YEARS OF TREATMENT
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    RHEUMATOLOGY, 2023, 62
  • [48] Long-Term Efficacy of Baricitinib in Patients with Rheumatoid Arthritis with Inadequate Response to Bdmards: Results from RA-BEYOND up to 6.9-Years of Treatment
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 517 - 518
  • [49] IMPACT OF SEROLOGIC STATUS ON CLINICAL RESPONSES TO UPADACITINIB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO BIOLOGIC DMARDS: SUB-GROUP ANALYSIS FROM THE PHASE 3 SELECT-CHOICE STUDY
    Rubbert-Roth, A.
    Sparks, J.
    Constantin, A.
    Xavier, R.
    Song, Y.
    Suboticki, J.
    Fleischmann, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1302 - 1303
  • [50] DELAYED CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE RECEIVING UPADACITINIB THERAPY
    D'Haens, Geert
    Seidelin, Jakob B.
    Lugering, Andreas
    Torres, Esther A.
    Fleisher, Mark
    Dryden, Gerald W.
    Lacerda, Ana P.
    Dubcenco, Elena
    Marced, Elena
    O'Brien, Daniel
    Feng, Tian
    Liu, Jianzhong
    Juillerat, Pascal
    GASTROENTEROLOGY, 2023, 164 (06) : S1085 - S1086
12345